Company Statement: GlaxoSmithKline announces the purchase of Stiefel Laboratories
MLex Summary: GlaxoSmithKline has reached an agreement with Stiefel. The deal, valued up to $3.6 billion, will create a leading dermatology specialist pharmaceutical business.GlaxoSmithKline plc (GSK) and Stiefel Laboratories Inc. today...To view the full article, register now.
Already a subscriber? Click here to view full article